LARGE SCALE PRODUCTION PROCESS FOR CAPPED AND UN-CAPPED ANTIBODY CYSTEINES AND THEIR USE IN THERAPEUTIC PROTEIN CONJUGATION
(Fri, 17 Aug 2018)
>> Read More
CALICHEAMICIN DERIVATIVES AND ANTIBODY DRUG CONJUGATES THEREOF (Fri, 03 Aug 2018)
>> Read More
HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS (Fri, 27 Jul 2018)
>> Read More
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS (Fri, 27 Jul 2018)
>> Read More
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES (Fri, 27 Jul 2018)
>> Read More
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS (Fri, 27 Jul 2018)
>> Read More
HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS (Fri, 27 Jul 2018)
>> Read More
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands (Fri, 20 Jul 2018)
>> Read More
BISPECIFIC ANTIBODIES (Fri, 29 Jun 2018)
>> Read More
Sulfonyl amide derivatives for the treatment of abnormal cell growth (Fri, 29 Jun 2018)
>> Read More
ARYL AND HETEROARYL FUSED LACTAMS (Thu, 28 Jun 2018)
>> Read More
GLP-1 Agonists and Uses Thereof (Fri, 22 Jun 2018)
>> Read More
Methyl- and Trifluoromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof (Fri, 22 Jun 2018)
>> Read More
GLP-1 RECEPTOR AGONISTS AND USES THEREOF (Fri, 22 Jun 2018)
>> Read More
GLP-1 RECEPTOR AGONISTS AND USES THEREOF (Sun, 17 Jun 2018)
>> Read More
N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS (Fri, 15 Jun 2018)
>> Read More
NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME (Fri, 01 Jun 2018)
>> Read More
Cycloalkyl-Linked Diheterocycle Derivatives (Fri, 01 Jun 2018)
>> Read More
HETEROARYLPHENOXY BENZAMIDE KAPPA OPIOID LIGANDS (Fri, 01 Jun 2018)
>> Read More
HETEROARYLPHENOXY BENZAMIDE KAPPA OPIOID LIGANDS (Fri, 01 Jun 2018)
>> Read More
CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF (Thu, 31 May 2018)
>> Read More
STABILITY-MODULATING LINKERS FOR USE WITH ANTIBODY DRUG CONJUGATES (Fri, 25 May 2018)
>> Read More
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS (Thu, 24 May 2018)
>> Read More
INTERMEDIATES AND METHODS FOR SYNTHESIZING CALICHEAMICIN DERIVATIVES (Fri, 18 May 2018)
>> Read More
IMMUNOGENIC POLYSACCHARIDE PROTEIN CONJUGATED COMPRISING A POLYSACCHARIDE DERIVED FROM B STREPTOCOCCUS GBS (Fri, 18 May 2018)
>> Read More
Carbonitrile derivatives as selective androgen receptor modulators (Fri, 18 May 2018)
>> Read More
COMBINATIONS COMPRISING A PYRROLIDINE-2,5-DIONE IDO1 INHIBITOR AND AN ANTI-BODY (Fri, 11 May 2018)
>> Read More
PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYRROLO[2,3-D]PYRIDINYL ACRYLAMIDES (Thu, 10 May 2018)
>> Read More
Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof (Fri, 13 Apr 2018)
>> Read More
ANTI-PTK7 ANTIBODY-DRUG CONJUGATES (Fri, 06 Apr 2018)
>> Read More
SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE (Fri, 06 Apr 2018)
>> Read More
CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA MALEATE (Fri, 30 Mar 2018)
>> Read More
RORC2 INHIBITORS AND METHODS OF USE THEREOF (Fri, 30 Mar 2018)
>> Read More
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS (Fri, 16 Mar 2018)
>> Read More
Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of RORc2 and methods of use thereof (Fri, 16 Mar 2018)
>> Read More
SOLID FORMS OF A SELECTIVE CDK4/6 INHIBITOR (Fri, 09 Mar 2018)
>> Read More
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,1-TRIFLUORO-4-HYDROXYBUTAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS (Fri, 09 Mar 2018)
>> Read More
COMBINATION OF PYRROLO [2, 3 -D]PYRIMIDINE DERIVATIVES WITH ONE OR MORE ADDITIONAL AGENTS AS INHIBITORS OF JANUS- RELATED KINASES (JAK) (Thu, 08 Mar 2018)
>> Read More
ANTAGONIST ANTIBODIES AGAINST GDF-8 AND USES THEREFOR (Fri, 02 Mar 2018)
>> Read More
TUMOR NECROSIS FACTOR-LIKE LIGAND 1A SPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF (Fri, 23 Feb 2018)
>> Read More
DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS (Fri, 23 Feb 2018)
>> Read More
DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS (Fri, 23 Feb 2018)
>> Read More
PYRIDOPYRIMDINONE CDK2/4/6 INHIBITORS (Fri, 23 Feb 2018)
>> Read More
DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS (Tue, 20 Feb 2018)
>> Read More
DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS (Fri, 16 Feb 2018)
>> Read More
CDK2/4/6 Inhibitors (Fri, 16 Feb 2018)
>> Read More
CDK2/4/6 INHIBITORS (Fri, 16 Feb 2018)
>> Read More
SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS (Fri, 09 Feb 2018)
>> Read More
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS (Fri, 09 Feb 2018)
>> Read More
HETEROARYL SULFONE-BASED CONJUGATION HANDLES, METHODS FOR THEIR PREPARATION, AND THEIR USE IN SYNTHESIZING ANTIBODY DRUG CONJUGATES (Fri, 09 Feb 2018)
>> Read More
Bifunctional Cytotoxic Agents Containing The Cti Pharmacophore (Sat, 03 Feb 2018)
>> Read More
CYCLIC PEPTIDES AS C5 A RECEPTOR ANTAGONISTS (Fri, 02 Feb 2018)
>> Read More
NOVEL PYRIMIDINE CARBOXAMIDES AS INHIBITORS OF VANIN-1 ENZYME (Fri, 19 Jan 2018)
>> Read More
Methyoxy-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof (Fri, 05 Jan 2018)
>> Read More
Immunogenic Compositions for Use in Pneumococcal Vaccines (Fri, 05 Jan 2018)
>> Read More
5,7-Dihydro-Pyrrolo-Pyridine Derivatives (Fri, 05 Jan 2018)
>> Read More
5,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES FOR TREATING NEUROLOGICAL AND NEURODEGENERATIVE DISEASES (Fri, 05 Jan 2018)
>> Read More
2-Thiopyrimidinones (Wed, 03 Jan 2018)
>> Read More
5,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES (Tue, 02 Jan 2018)
>> Read More
N-(2-(2-AMINO-6-SUBSTITUTED-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]OXAZIN-8a(8H)-YL)-THIAZOL-4-YL) AMIDES (Fri, 29 Dec 2017)
>> Read More
COMBINATION THERAPY FOR TUBERCULOSIS (Fri, 29 Dec 2017)
>> Read More
ANTI-ESTROGENIC COMPOUNDS (Fri, 22 Dec 2017)
>> Read More
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof (Fri, 15 Dec 2017)
>> Read More
NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-D]PYRIMIDINES AS LRRK2 INHIBITORS (Thu, 14 Dec 2017)
>> Read More
SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS (Fri, 08 Dec 2017)
>> Read More
SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES, AND USE THEREOF AS A PRMT5 INHIBITOR (Thu, 07 Dec 2017)
>> Read More
CRYSTALLINE FORMS OF 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOLE SUITABLE FOR THE TREATMENT OF ABNORMAL CELL GROWTH IN MAMMALS (Thu, 07 Dec 2017)
>> Read More
Heterocyclic acrylamide (Sat, 02 Dec 2017)
>> Read More
INTERFERON BETA ANTIBODIES AND USES THEREOF (Fri, 03 Nov 2017)
>> Read More
INTERFERON BETA ANTIBODIES AND USES THEREOF (Fri, 03 Nov 2017)
>> Read More
N-ACYLPIPERIDINE ETHER TROPOMYOSIN-RELATED KINASE INHIBITORS (Fri, 27 Oct 2017)
>> Read More
SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS WITH RENAL IMPAIRMENT OR CHRONIC KIDNEY DISEASE (Fri, 27 Oct 2017)
>> Read More
N-[2-(2-AMINO-6,6-DISUBSTITUTED-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL)-1,3-THIAZOL-4-YL] AMIDES (Fri, 27 Oct 2017)
>> Read More
2-amino-6-methy1-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides (Fri, 27 Oct 2017)
>> Read More
CRYSTALLINE FORMS OF LORLATINIB MALEATE (Fri, 13 Oct 2017)
>> Read More
Bruton's Tyrosine Kinase Inhibitors (Fri, 06 Oct 2017)
>> Read More
CRYSTALLINE SOLID FORMS OF 6-CARBOXY-2-(3,5-DICHLOROPHENYL)-BENZOXAZOLE (Fri, 29 Sep 2017)
>> Read More
BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS (Fri, 29 Sep 2017)
>> Read More
2-THIOPYRIMIDINONES (Fri, 29 Sep 2017)
>> Read More
METHODS OF TREATING OR REDUCING THE RISK OF CARDIOVASCULAR EVENTS AND RELATED DISEASES USING SGLT-2 INHIBITORS (Fri, 15 Sep 2017)
>> Read More
PROCESS AND INTERMEDIATES FOR THE PREPARATION OF PREGABALIN (Thu, 14 Sep 2017)
>> Read More
METHODS OF USE AND COMBINATIONS (Fri, 08 Sep 2017)
>> Read More
PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES AS JAK-INHIBITORS (Fri, 01 Sep 2017)
>> Read More
6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE COMPOUNDS (Fri, 01 Sep 2017)
>> Read More
6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds (Fri, 01 Sep 2017)
>> Read More
Pyrazolo[1,5-a]pyrazin-4-yl derivatives as JAK-inhibitors (Fri, 01 Sep 2017)
>> Read More
Pyrrolo [2, 3 -d]pyrimidine derivatives as inhibitors of janus- related kinases (JAK) (Sat, 26 Aug 2017)
>> Read More
AMINOPYRIMIDINYL COMPOUNDS (Fri, 25 Aug 2017)
>> Read More
PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES (Fri, 25 Aug 2017)
>> Read More
PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES (Fri, 25 Aug 2017)
>> Read More
RORC2 INHIBITORS AND METHODS OF USE THEREOF (Fri, 18 Aug 2017)
>> Read More
ARYL AND HETEROARYL FUSED LACTAMS (Fri, 18 Aug 2017)
>> Read More
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof (Fri, 18 Aug 2017)
>> Read More
THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME (Fri, 18 Aug 2017)
>> Read More
Neisseria meningitidis compositions and methods thereof (Fri, 18 Aug 2017)
>> Read More
Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same (Fri, 18 Aug 2017)
>> Read More
Glycoconjugation processes and compositions (Fri, 11 Aug 2017)
>> Read More
THERAPEUTIC NANOPARTICLES HAVING EGFR LIGANDS AND METHODS OF MAKING AND USING SAME (Fri, 11 Aug 2017)
>> Read More
TUBULYSIN ANALOGS AND METHODS FOR THEIR PREPARATION (Fri, 11 Aug 2017)
>> Read More
NOVEL 3-AMINO-PYRROLO[3,4-C]PYRAZOLE-5(1H, 4H,6H) CARBALDEHYDE DERIVATIVES (Fri, 04 Aug 2017)
>> Read More
ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION (Fri, 04 Aug 2017)
>> Read More
Pyrazolopyrimidine Compounds (Fri, 21 Jul 2017)
>> Read More
6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-d]AZEPINE DOPAMINE D3 LIGANDS (Fri, 21 Jul 2017)
>> Read More
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands (Fri, 21 Jul 2017)
>> Read More
Tropomyosin-Related Kinase Inhibitors Containing Both A 1H-Pyrazole And A Pyrimidine Moiety (Fri, 14 Jul 2017)
>> Read More
Imidazopyridazine derivatives as modulators of the GABAA receptor activity (Fri, 14 Jul 2017)
>> Read More
Salt forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-hepatonic acid (Fri, 07 Jul 2017)
>> Read More
SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS (Fri, 07 Jul 2017)
>> Read More
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors (Fri, 07 Jul 2017)
>> Read More
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors (Fri, 30 Jun 2017)
>> Read More
SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE A AND C INHIBITORS (Fri, 30 Jun 2017)
>> Read More
AMINOPYRIMIDINYL COMPOUNDS AS JAK INHIBITORS (Thu, 29 Jun 2017)
>> Read More
NOVEL FUSED PYRIDINE COMPOUNDS AS CASEIN KINASE INHIBITORS (Thu, 22 Jun 2017)
>> Read More
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands (Fri, 16 Jun 2017)
>> Read More
SUBSTITUTED PYRIDO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES (Fri, 16 Jun 2017)
>> Read More
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR (Fri, 16 Jun 2017)
>> Read More
4-(BIPHEN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZINE DERIVATIVES OF FORMULA (I) AS GABA RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF EPILEPSY AND PAIN (Fri, 16 Jun 2017)
>> Read More
SITE SPECIFIC HER2 ANTIBODY DRUG CONJUGATES (Fri, 09 Jun 2017)
>> Read More
ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION (Fri, 09 Jun 2017)
>> Read More
Site specific HER2 antibody drug conjugates (Fri, 09 Jun 2017)
>> Read More
Antibodies and antibody fragments for site-specific conjugation (Fri, 09 Jun 2017)
>> Read More
SITE SPECIFIC HER2 ANTIBODY DRUG CONJUGATES (Fri, 02 Jun 2017)
>> Read More
BENZAMIDE AND HETEROBENZAMIDE COMPOUNDS (Fri, 02 Jun 2017)
>> Read More
2-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides (Fri, 02 Jun 2017)
>> Read More
SITE SPECIFIC HER2 ANTIBODY DRUG CONJUGATES (Wed, 31 May 2017)
>> Read More
ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION (Wed, 31 May 2017)
>> Read More
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES (Sat, 27 May 2017)
>> Read More
Imidazopyridazine Compounds (Fri, 26 May 2017)
>> Read More
Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole (Thu, 25 May 2017)
>> Read More
TISSUE-SPECIFIC GENOME ENGINEERING USING CRISPR-CAS9 (Fri, 19 May 2017)
>> Read More
TISSUE-SPECIFIC GENOME ENGINEERING USING CRISPR-CAS9 (Fri, 19 May 2017)
>> Read More
METHODS OF DETERMINING FEATURES OF POLYMERIC NANOPARTICLES THAT INCLUDE A THERAPEUTIC AGENT (Fri, 19 May 2017)
>> Read More
Triazine compounds as PI3 kinase and mTOR inhibitors (Fri, 05 May 2017)
>> Read More
ANTI-IL-2 ANTIBODIES AND COMPOSITIONS AND USES THEREOF (Fri, 28 Apr 2017)
>> Read More
Anti-IL-2 antibodies and compositions and uses thereof (Fri, 28 Apr 2017)
>> Read More
ANTI-IL-2 ANTIBODIES AND COMPOSITIONS AND USES THEREOF (Mon, 24 Apr 2017)
>> Read More
METHOD OF CELL CULTURE (Fri, 21 Apr 2017)
>> Read More
IMIDAZOPYRIDAZINE DERIVATIVES AS MODULATORS OF THE GABAA RECEPTOR ACTIVITY. (Thu, 20 Apr 2017)
>> Read More
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides (Wed, 12 Apr 2017)
>> Read More
Cyclopropabenzofuranyl pyridopyrazinediones (Fri, 07 Apr 2017)
>> Read More
SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO}METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE (Thu, 06 Apr 2017)
>> Read More
N-[2-(3-AMINO-2,5-DIMETHYL-1,1-DIOXIDO-5,6-DIHYDRO-2H-1,2,4-THIADIAZIN-5-YL)-1,3-THIAZOL-4-YL] AMIDES (Fri, 31 Mar 2017)
>> Read More
N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]OXAZIN-8a(8H)-yl)-thiazol-4-yl) amides (Fri, 31 Mar 2017)
>> Read More
N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl)-1,3-thiazol-4-yl]amides (Fri, 31 Mar 2017)
>> Read More
CELLS AND METHOD OF CELL CULTURE (Fri, 31 Mar 2017)
>> Read More
N-[2-(3-AMINO-2,5-DIMETHYL-1,1-DIOXIDO-5,6-DIHYDRO-2H-1,2,4-THIADIAZIN-5-YL)-1,3-THIAZOL-4-YL] AMIDES USEFUL AS BACE INHIBITORS (Fri, 31 Mar 2017)
>> Read More
TETRAHYDROPYRANO[3,4-D][1,3]OXAZIN DERIVATIVES AND THEIR USE AS BACE INHIBITORS (Fri, 31 Mar 2017)
>> Read More
N-[2-(2-AMINO-6,6-DISUBSTITUTED-4, 4A, 5, 6-TETRAHYDROPYRANO [3,4-D][1,3] THIAZIN-8A (8H)-YL) -1, 3-THIAZOL-4-YL] AMIDES (Fri, 31 Mar 2017)
>> Read More
N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3] thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl] amides (Fri, 31 Mar 2017)
>> Read More
NOVEL IMIDAZO [4,5-C] QUINOLINE AND IMIDAZO [4,5-C][1,5] NAPHTHYRIDINE DERIVATIVES AS LRRK2 INHIBITORS (Fri, 24 Mar 2017)
>> Read More
Novel imidazo (4,5-c) quinoline and imidazo (4,5-c)(1,5) naphthyridine derivatives as LRRK2 inhibitors (Fri, 24 Mar 2017)
>> Read More
HUMANIZED ANTIBODIES (Fri, 17 Mar 2017)
>> Read More
TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF (Fri, 17 Mar 2017)
>> Read More
Crystalline form of 6-[(4R)-4-methyl-1,2-dioxido-1,2,6-thiadiazinan-2-yl]iosoquinoline-1-carbonitrile (Fri, 17 Mar 2017)
>> Read More
Pyrazolopyridines and pyrazolopyrimidines (Fri, 17 Mar 2017)
>> Read More
Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors (Fri, 17 Mar 2017)
>> Read More
Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof (Fri, 17 Mar 2017)
>> Read More
Heteroaromatic compounds and their use as dopamine D1 ligands (Fri, 03 Mar 2017)
>> Read More
BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS (Fri, 03 Mar 2017)
>> Read More
BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS (Fri, 03 Mar 2017)
>> Read More
Aminopyrimidinyl compounds as JAK inhibitors (Fri, 03 Mar 2017)
>> Read More
Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole (Fri, 03 Mar 2017)
>> Read More
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators (Fri, 03 Mar 2017)
>> Read More
Cycloalkyl-Linked Diheterocycle Derivatives (Fri, 24 Feb 2017)
>> Read More
TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF (Fri, 24 Feb 2017)
>> Read More
Tissue factor pathway inhibitor antibodies and uses thereof (Fri, 24 Feb 2017)
>> Read More
Crystalline form of 6-[(4r)-4-methyl-1,2-dioxido-1,2,6-thiadiazinan-2-yl]isoquinoline-1-carbonitrile (Thu, 23 Feb 2017)
>> Read More
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides (Thu, 23 Feb 2017)
>> Read More
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of asgpr (Thu, 23 Feb 2017)
>> Read More
TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES (Mon, 20 Feb 2017)
>> Read More
Heterocyclic compounds and their use as dopamine D1 ligands (Fri, 17 Feb 2017)
>> Read More
BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS (Fri, 17 Feb 2017)
>> Read More
3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE (Fri, 17 Feb 2017)
>> Read More
3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE (Fri, 17 Feb 2017)
>> Read More
BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS (Fri, 17 Feb 2017)
>> Read More
Bicyclic-fused heteroaryl or aryl compounds (Fri, 17 Feb 2017)
>> Read More
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof (Thu, 16 Feb 2017)
>> Read More
Heteroaromatic compounds and their use as dopamine D1 ligands (Fri, 10 Feb 2017)
>> Read More
Heteroaromatic compounds and their use as dopamine D1 ligands (Fri, 10 Feb 2017)
>> Read More
CRYSTALLINE FORM OF LORLATINIB FREE BASE (Fri, 10 Feb 2017)
>> Read More
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,1-TRIFLUORO-4-HYDROXYBUTAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS (Fri, 10 Feb 2017)
>> Read More
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors (Fri, 10 Feb 2017)
>> Read More
Crystalline form of lorlatinib free base (Fri, 10 Feb 2017)
>> Read More
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors (Fri, 03 Feb 2017)
>> Read More
Stability-modulating linkers for use with antibody drug conjugates (Fri, 03 Feb 2017)
>> Read More
Imidazopyridazine compounds (Fri, 03 Feb 2017)
>> Read More
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,1-TRIFLUORO-4-HYDROXYBUTAN-2-YL CARBAMATE DERIVATIVES (Wed, 01 Feb 2017)
>> Read More
CRYSTALLINE FORM OF LORLATINIB FREE BASE (Wed, 01 Feb 2017)
>> Read More
IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF (Fri, 27 Jan 2017)
>> Read More
ANTIBODIES TO COAGULATION FACTOR XIA AND USES THEREOF (Fri, 27 Jan 2017)
>> Read More
IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF (Fri, 27 Jan 2017)
>> Read More
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof (Fri, 27 Jan 2017)
>> Read More
DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC AND RELATED DISORDERS (Thu, 26 Jan 2017)
>> Read More
IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF (Sun, 22 Jan 2017)
>> Read More
ANTI-NOTCH3 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES (Fri, 20 Jan 2017)
>> Read More
Spliceostatin analogs and methods for their preparation (Fri, 20 Jan 2017)
>> Read More
Pyrimidine derivatives (Fri, 20 Jan 2017)
>> Read More
PYRIMIDINE DERIVATIVES (Fri, 20 Jan 2017)
>> Read More
PROCEDURES FOR THE EXTRACTION AND ISOLATION OF BACTERIAL CAPSULAR POLYSACCHARIDES FOR USE AS VACCINES OR LINKED TO PROTEINS AS CONJUGATES VACCINES (Thu, 19 Jan 2017)
>> Read More
PYRIMIDINE DERIVATIVES (Mon, 16 Jan 2017)
>> Read More
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides (Fri, 13 Jan 2017)
>> Read More
IMMUNOGENIC GLYCOPROTEIN CONJUGATES (Fri, 13 Jan 2017)
>> Read More
SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH (Fri, 06 Jan 2017)
>> Read More
3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors (Fri, 06 Jan 2017)
>> Read More
SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS (Fri, 30 Dec 2016)
>> Read More
NOVEL PYRIDINE PYRAZINONES AS BET-FAMILY BROMODOMAIN INHIBITORS (Fri, 23 Dec 2016)
>> Read More
TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS (Fri, 23 Dec 2016)
>> Read More
NOVEL PYRIDO[2,3-B]PYRAZINONES AS BET-FAMILY BROMODOMAIN INHIBITORS (Fri, 23 Dec 2016)
>> Read More
TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS (Fri, 23 Dec 2016)
>> Read More
NOVEL PYRIDINE PYRAZINONES AS BRD4 INHIBITORS (Mon, 19 Dec 2016)
>> Read More
GLUCAGON RECEPTOR MODULATORS (Fri, 16 Dec 2016)
>> Read More
Bispecific heterodimeric diabodies and uses thereof (Fri, 16 Dec 2016)
>> Read More
Pyrazolopyridines and pyrazolopyrimidines (Wed, 14 Dec 2016)
>> Read More
NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME (Fri, 09 Dec 2016)
>> Read More
NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME (Fri, 09 Dec 2016)
>> Read More
<i>Neisseria meningitidis </i>composition and methods thereof (Fri, 02 Dec 2016)
>> Read More
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors (Fri, 02 Dec 2016)
>> Read More
Bicyclic-fused heteroaryl or aryl compounds (Fri, 02 Dec 2016)
>> Read More
Pyrazolopyridines and pyrazolopyrimidines (Fri, 02 Dec 2016)
>> Read More
Drug loaded polymeric nanoparticles and methods of making and using same (Fri, 25 Nov 2016)
>> Read More
Substituted dihydroisoquinolinone compounds (Fri, 25 Nov 2016)
>> Read More
Process for annealing amorphous atorvastatin (Fri, 18 Nov 2016)
>> Read More
COMBINATIONS COMPRISING A PYRROLIDINE-2,5-DIONE IDO1 INHIBITOR AND AN ANTI-BODY (Fri, 18 Nov 2016)
>> Read More
COMBINATIONS COMPRISING A PYRROLIDINE-2,5-DIONE IDO1 INHIBITOR AND AN ANTI-BODY (Fri, 18 Nov 2016)
>> Read More
POLYMORPH FORMS OF PYRROLIDINE-2,5-DIONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE AS IDO1 INHIBITORS (Fri, 18 Nov 2016)
>> Read More
Carbonitrile derivatives as selective androgen receptor modulators (Fri, 18 Nov 2016)
>> Read More
POLYMORPH FORMS OF PYRROLIDINE-2,5-DIONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF (Tue, 15 Nov 2016)
>> Read More
COMBINATION THERAPIES COMPRISING A PYRROLIDINE-2,5-DIONE IDO1 INHIBITOR AND AN ANTI-PD1/ANTI-PD-L1 ANTIBODY (Tue, 15 Nov 2016)
>> Read More
COMBINATION THERAPIES COMPRISING A PYRROLIDINE-2,5-DIONE IDO1 INHIBITOR (Tue, 15 Nov 2016)
>> Read More
2-thiopyrimidinones (Fri, 11 Nov 2016)
>> Read More
2-THIOPYRIMIDINONES (Fri, 11 Nov 2016)
>> Read More
PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL, PYRROLO[2,3-B]PYRIDINYL ACRYLAMIDES AND EPOXIDES THEREOF (Fri, 11 Nov 2016)
>> Read More
GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF (Fri, 11 Nov 2016)
>> Read More
Anti-PTK7 antibody-drug conjugates (Fri, 11 Nov 2016)
>> Read More
2-thiopyrimidinones (Fri, 11 Nov 2016)
>> Read More
PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL, PYRROLO[2,3-B]PYRIDINYL ACRYLAMIDES AND EPOXIDES THEREOF (Fri, 11 Nov 2016)
>> Read More
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR (Fri, 11 Nov 2016)
>> Read More
Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction (Fri, 11 Nov 2016)
>> Read More
Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof (Fri, 11 Nov 2016)
>> Read More
Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders (Thu, 10 Nov 2016)
>> Read More
2-THIOPYRIMIDINONES (Sun, 06 Nov 2016)
>> Read More
GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF (Sat, 05 Nov 2016)
>> Read More
ANTI-ESTROGENIC COMPOUNDS (Fri, 04 Nov 2016)
>> Read More
ANTI-ESTROGENIC COMPOUNDS (Fri, 28 Oct 2016)
>> Read More
CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA MALEATE (Fri, 28 Oct 2016)
>> Read More
ANTI-ESTROGENIC COMPOUNDS (Fri, 28 Oct 2016)
>> Read More
CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA MALEATE (Fri, 28 Oct 2016)
>> Read More
Cycloalkyl-linked diheterocycle derivatives (Fri, 28 Oct 2016)
>> Read More
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides (Thu, 27 Oct 2016)
>> Read More
NOVEL 3,4-DISUBSTITUTED-1H-PYRROLO[2,3-B]PYRIDINES AND 4,5-DISUBSTITUTED-7H-PYRROLO[2,3-C]PYRIDAZINES AS LRRK2 INHIBITORS (Thu, 27 Oct 2016)
>> Read More
CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA MALEATE (Tue, 25 Oct 2016)
>> Read More
Diacylglycerol acyltransferase 2 inhibitors (Fri, 21 Oct 2016)
>> Read More
2-thiopyrimidinones (Fri, 21 Oct 2016)
>> Read More
Heteroaromatic compounds and their use as dopamine D1 ligands (Fri, 21 Oct 2016)
>> Read More
Crystalline form of 6-((4R)-4-methyl-1,2-dioxido-1,2,6-thiadiazinan-2-yl)isoquinoline-1-carbonitrile (Fri, 21 Oct 2016)
>> Read More
Bicyclic-fused heteroaryl or aryl compounds and their use as IRAK4 inhibitors (Fri, 14 Oct 2016)
>> Read More
PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYRROLO[2,3-D]PYRIDINYL ACRYLAMIDES (Thu, 13 Oct 2016)
>> Read More
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides (Fri, 07 Oct 2016)
>> Read More
BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE (Fri, 30 Sep 2016)
>> Read More
Bifunctional cytotoxic agents containing the CTI pharmacophore (Fri, 30 Sep 2016)
>> Read More
Neisseria meningitidis compositions and methods thereof (Fri, 30 Sep 2016)
>> Read More
Heteroaromatic compounds and their use as dopamine D1 ligands (Fri, 30 Sep 2016)
>> Read More
BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE (Fri, 23 Sep 2016)
>> Read More
HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF (Fri, 23 Sep 2016)
>> Read More
3-indol substituted derivatives, pharmaceutical compositions and methods for use (Fri, 23 Sep 2016)
>> Read More
NOVEL 3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE (Fri, 23 Sep 2016)
>> Read More
Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use (Fri, 23 Sep 2016)
>> Read More
NOVEL 3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE (Fri, 23 Sep 2016)
>> Read More
Chromene and 1,1 a,2,7b-tetrahydrocyclopropa[c]chromene pyridopyrazinediones as gamma-secretase modulators (Fri, 23 Sep 2016)
>> Read More
BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE (Wed, 21 Sep 2016)
>> Read More
Intermediates and methods for synthesizing calicheamicin derivatives (Fri, 02 Sep 2016)
>> Read More
SUBSTITUTED NUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS (Fri, 02 Sep 2016)
>> Read More
Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders (Fri, 02 Sep 2016)
>> Read More
Substituted nucleoside derivatives useful as anticancer agents (Fri, 02 Sep 2016)
>> Read More
SUBSTITUTED NUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS (Fri, 26 Aug 2016)
>> Read More
SUBSTITUTED NUCLEOSIDE DERIVATIVES AS PRMT5 INHIBITORS (Thu, 25 Aug 2016)
>> Read More
ANTAGONISTS OF PROSTAGLANDIN EP3 RECEPTOR (Thu, 18 Aug 2016)
>> Read More
Process for the preparation of voriconazole and analogues thereof (Fri, 12 Aug 2016)
>> Read More
NOVEL CYCLOPROPABENZOFURANYL PYRIDOPYRAZINEDIONES (Fri, 12 Aug 2016)
>> Read More
USE OF ACETYL-COA CARBOXYLASE INHIBITORS FOR TREATING ACNE VULGARIS (Fri, 05 Aug 2016)
>> Read More
Combination Therapy for Tuberculosis (Fri, 05 Aug 2016)
>> Read More
N-Acylpyrrolidine Ether Tropomyosin-Related Kinase Inhibitors (Fri, 05 Aug 2016)
>> Read More
Novel Cyclopropabenzofuranyl Pyridopyrazinediones (Fri, 05 Aug 2016)
>> Read More
SULFONAMIDE-SUBSITUTED INDOLE MODULATORS OF RORC2 AND METHODS OF USE THEREOF (Fri, 05 Aug 2016)
>> Read More
METHOXY-SUBSTITUTED PYRROLOPYRIDINE MODULATORS OF RORC2 AND METHODS OF USE THEREOF (Fri, 05 Aug 2016)
>> Read More
METHOXY-SUBSTITUTED PYRROLOPYRIDINE MODULATORS OF RORC2 AND METHODS OF USE THEREOF (Fri, 05 Aug 2016)
>> Read More
NOVEL CYCLOPROPABENZOFURANYL PYRIDOPYRAZINEDIONES (Thu, 04 Aug 2016)
>> Read More
KAT II INHIBITORS (Mon, 01 Aug 2016)
>> Read More
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR (Fri, 22 Jul 2016)
>> Read More
Therapeutic Antibody (Fri, 22 Jul 2016)
>> Read More
CRIZOTINIB FOR USE IN THE TREATMENT OF CANCER (Fri, 22 Jul 2016)
>> Read More
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES (Fri, 22 Jul 2016)
>> Read More
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof (Fri, 22 Jul 2016)
>> Read More
Immunogenic compositions for use in pneumococcal vaccines (Fri, 22 Jul 2016)
>> Read More
Bifunctional cytotoxic agents (Fri, 22 Jul 2016)
>> Read More
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES (Sat, 16 Jul 2016)
>> Read More
Heteroaromatic compounds and their use as dopamine D1 ligands (Fri, 15 Jul 2016)
>> Read More
DOSAGE REGIMEN FOR MADCAM ANTAGONISTS (Fri, 15 Jul 2016)
>> Read More
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof (Fri, 15 Jul 2016)
>> Read More
Dosage regimen for MAdCAM antagonists (Fri, 15 Jul 2016)
>> Read More
>> Read More
CALICHEAMICIN DERIVATIVES AND ANTIBODY DRUG CONJUGATES THEREOF (Fri, 03 Aug 2018)
>> Read More
HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS (Fri, 27 Jul 2018)
>> Read More
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS (Fri, 27 Jul 2018)
>> Read More
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES (Fri, 27 Jul 2018)
>> Read More
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS (Fri, 27 Jul 2018)
>> Read More
HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS (Fri, 27 Jul 2018)
>> Read More
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands (Fri, 20 Jul 2018)
>> Read More
BISPECIFIC ANTIBODIES (Fri, 29 Jun 2018)
>> Read More
Sulfonyl amide derivatives for the treatment of abnormal cell growth (Fri, 29 Jun 2018)
>> Read More
ARYL AND HETEROARYL FUSED LACTAMS (Thu, 28 Jun 2018)
>> Read More
GLP-1 Agonists and Uses Thereof (Fri, 22 Jun 2018)
>> Read More
Methyl- and Trifluoromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof (Fri, 22 Jun 2018)
>> Read More
GLP-1 RECEPTOR AGONISTS AND USES THEREOF (Fri, 22 Jun 2018)
>> Read More
GLP-1 RECEPTOR AGONISTS AND USES THEREOF (Sun, 17 Jun 2018)
>> Read More
N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS (Fri, 15 Jun 2018)
>> Read More
NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME (Fri, 01 Jun 2018)
>> Read More
Cycloalkyl-Linked Diheterocycle Derivatives (Fri, 01 Jun 2018)
>> Read More
HETEROARYLPHENOXY BENZAMIDE KAPPA OPIOID LIGANDS (Fri, 01 Jun 2018)
>> Read More
HETEROARYLPHENOXY BENZAMIDE KAPPA OPIOID LIGANDS (Fri, 01 Jun 2018)
>> Read More
CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF (Thu, 31 May 2018)
>> Read More
STABILITY-MODULATING LINKERS FOR USE WITH ANTIBODY DRUG CONJUGATES (Fri, 25 May 2018)
>> Read More
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS (Thu, 24 May 2018)
>> Read More
INTERMEDIATES AND METHODS FOR SYNTHESIZING CALICHEAMICIN DERIVATIVES (Fri, 18 May 2018)
>> Read More
IMMUNOGENIC POLYSACCHARIDE PROTEIN CONJUGATED COMPRISING A POLYSACCHARIDE DERIVED FROM B STREPTOCOCCUS GBS (Fri, 18 May 2018)
>> Read More
Carbonitrile derivatives as selective androgen receptor modulators (Fri, 18 May 2018)
>> Read More
COMBINATIONS COMPRISING A PYRROLIDINE-2,5-DIONE IDO1 INHIBITOR AND AN ANTI-BODY (Fri, 11 May 2018)
>> Read More
PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYRROLO[2,3-D]PYRIDINYL ACRYLAMIDES (Thu, 10 May 2018)
>> Read More
Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof (Fri, 13 Apr 2018)
>> Read More
ANTI-PTK7 ANTIBODY-DRUG CONJUGATES (Fri, 06 Apr 2018)
>> Read More
SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE (Fri, 06 Apr 2018)
>> Read More
CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA MALEATE (Fri, 30 Mar 2018)
>> Read More
RORC2 INHIBITORS AND METHODS OF USE THEREOF (Fri, 30 Mar 2018)
>> Read More
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS (Fri, 16 Mar 2018)
>> Read More
Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of RORc2 and methods of use thereof (Fri, 16 Mar 2018)
>> Read More
SOLID FORMS OF A SELECTIVE CDK4/6 INHIBITOR (Fri, 09 Mar 2018)
>> Read More
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,1-TRIFLUORO-4-HYDROXYBUTAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS (Fri, 09 Mar 2018)
>> Read More
COMBINATION OF PYRROLO [2, 3 -D]PYRIMIDINE DERIVATIVES WITH ONE OR MORE ADDITIONAL AGENTS AS INHIBITORS OF JANUS- RELATED KINASES (JAK) (Thu, 08 Mar 2018)
>> Read More
ANTAGONIST ANTIBODIES AGAINST GDF-8 AND USES THEREFOR (Fri, 02 Mar 2018)
>> Read More
TUMOR NECROSIS FACTOR-LIKE LIGAND 1A SPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF (Fri, 23 Feb 2018)
>> Read More
DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS (Fri, 23 Feb 2018)
>> Read More
DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS (Fri, 23 Feb 2018)
>> Read More
PYRIDOPYRIMDINONE CDK2/4/6 INHIBITORS (Fri, 23 Feb 2018)
>> Read More
DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS (Tue, 20 Feb 2018)
>> Read More
DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS (Fri, 16 Feb 2018)
>> Read More
CDK2/4/6 Inhibitors (Fri, 16 Feb 2018)
>> Read More
CDK2/4/6 INHIBITORS (Fri, 16 Feb 2018)
>> Read More
SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS (Fri, 09 Feb 2018)
>> Read More
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS (Fri, 09 Feb 2018)
>> Read More
HETEROARYL SULFONE-BASED CONJUGATION HANDLES, METHODS FOR THEIR PREPARATION, AND THEIR USE IN SYNTHESIZING ANTIBODY DRUG CONJUGATES (Fri, 09 Feb 2018)
>> Read More
Bifunctional Cytotoxic Agents Containing The Cti Pharmacophore (Sat, 03 Feb 2018)
>> Read More
CYCLIC PEPTIDES AS C5 A RECEPTOR ANTAGONISTS (Fri, 02 Feb 2018)
>> Read More
NOVEL PYRIMIDINE CARBOXAMIDES AS INHIBITORS OF VANIN-1 ENZYME (Fri, 19 Jan 2018)
>> Read More
Methyoxy-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof (Fri, 05 Jan 2018)
>> Read More
Immunogenic Compositions for Use in Pneumococcal Vaccines (Fri, 05 Jan 2018)
>> Read More
5,7-Dihydro-Pyrrolo-Pyridine Derivatives (Fri, 05 Jan 2018)
>> Read More
5,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES FOR TREATING NEUROLOGICAL AND NEURODEGENERATIVE DISEASES (Fri, 05 Jan 2018)
>> Read More
2-Thiopyrimidinones (Wed, 03 Jan 2018)
>> Read More
5,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES (Tue, 02 Jan 2018)
>> Read More
N-(2-(2-AMINO-6-SUBSTITUTED-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]OXAZIN-8a(8H)-YL)-THIAZOL-4-YL) AMIDES (Fri, 29 Dec 2017)
>> Read More
COMBINATION THERAPY FOR TUBERCULOSIS (Fri, 29 Dec 2017)
>> Read More
ANTI-ESTROGENIC COMPOUNDS (Fri, 22 Dec 2017)
>> Read More
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof (Fri, 15 Dec 2017)
>> Read More
NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-D]PYRIMIDINES AS LRRK2 INHIBITORS (Thu, 14 Dec 2017)
>> Read More
SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS (Fri, 08 Dec 2017)
>> Read More
SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES, AND USE THEREOF AS A PRMT5 INHIBITOR (Thu, 07 Dec 2017)
>> Read More
CRYSTALLINE FORMS OF 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOLE SUITABLE FOR THE TREATMENT OF ABNORMAL CELL GROWTH IN MAMMALS (Thu, 07 Dec 2017)
>> Read More
Heterocyclic acrylamide (Sat, 02 Dec 2017)
>> Read More
INTERFERON BETA ANTIBODIES AND USES THEREOF (Fri, 03 Nov 2017)
>> Read More
INTERFERON BETA ANTIBODIES AND USES THEREOF (Fri, 03 Nov 2017)
>> Read More
N-ACYLPIPERIDINE ETHER TROPOMYOSIN-RELATED KINASE INHIBITORS (Fri, 27 Oct 2017)
>> Read More
SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS WITH RENAL IMPAIRMENT OR CHRONIC KIDNEY DISEASE (Fri, 27 Oct 2017)
>> Read More
N-[2-(2-AMINO-6,6-DISUBSTITUTED-4,4a,5,6-TETRAHYDROPYRANO[3,4-d][1,3]THIAZIN-8a(8H)-YL)-1,3-THIAZOL-4-YL] AMIDES (Fri, 27 Oct 2017)
>> Read More
2-amino-6-methy1-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides (Fri, 27 Oct 2017)
>> Read More
CRYSTALLINE FORMS OF LORLATINIB MALEATE (Fri, 13 Oct 2017)
>> Read More
Bruton's Tyrosine Kinase Inhibitors (Fri, 06 Oct 2017)
>> Read More
CRYSTALLINE SOLID FORMS OF 6-CARBOXY-2-(3,5-DICHLOROPHENYL)-BENZOXAZOLE (Fri, 29 Sep 2017)
>> Read More
BENZENESULFONAMIDES USEFUL AS SODIUM CHANNEL INHIBITORS (Fri, 29 Sep 2017)
>> Read More
2-THIOPYRIMIDINONES (Fri, 29 Sep 2017)
>> Read More
METHODS OF TREATING OR REDUCING THE RISK OF CARDIOVASCULAR EVENTS AND RELATED DISEASES USING SGLT-2 INHIBITORS (Fri, 15 Sep 2017)
>> Read More
PROCESS AND INTERMEDIATES FOR THE PREPARATION OF PREGABALIN (Thu, 14 Sep 2017)
>> Read More
METHODS OF USE AND COMBINATIONS (Fri, 08 Sep 2017)
>> Read More
PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES AS JAK-INHIBITORS (Fri, 01 Sep 2017)
>> Read More
6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE COMPOUNDS (Fri, 01 Sep 2017)
>> Read More
6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds (Fri, 01 Sep 2017)
>> Read More
Pyrazolo[1,5-a]pyrazin-4-yl derivatives as JAK-inhibitors (Fri, 01 Sep 2017)
>> Read More
Pyrrolo [2, 3 -d]pyrimidine derivatives as inhibitors of janus- related kinases (JAK) (Sat, 26 Aug 2017)
>> Read More
AMINOPYRIMIDINYL COMPOUNDS (Fri, 25 Aug 2017)
>> Read More
PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES (Fri, 25 Aug 2017)
>> Read More
PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES (Fri, 25 Aug 2017)
>> Read More
RORC2 INHIBITORS AND METHODS OF USE THEREOF (Fri, 18 Aug 2017)
>> Read More
ARYL AND HETEROARYL FUSED LACTAMS (Fri, 18 Aug 2017)
>> Read More
Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof (Fri, 18 Aug 2017)
>> Read More
THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME (Fri, 18 Aug 2017)
>> Read More
Neisseria meningitidis compositions and methods thereof (Fri, 18 Aug 2017)
>> Read More
Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same (Fri, 18 Aug 2017)
>> Read More
Glycoconjugation processes and compositions (Fri, 11 Aug 2017)
>> Read More
THERAPEUTIC NANOPARTICLES HAVING EGFR LIGANDS AND METHODS OF MAKING AND USING SAME (Fri, 11 Aug 2017)
>> Read More
TUBULYSIN ANALOGS AND METHODS FOR THEIR PREPARATION (Fri, 11 Aug 2017)
>> Read More
NOVEL 3-AMINO-PYRROLO[3,4-C]PYRAZOLE-5(1H, 4H,6H) CARBALDEHYDE DERIVATIVES (Fri, 04 Aug 2017)
>> Read More
ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION (Fri, 04 Aug 2017)
>> Read More
Pyrazolopyrimidine Compounds (Fri, 21 Jul 2017)
>> Read More
6,7,8,9-TETRAHYDRO-5H-PYRIDO[2,3-d]AZEPINE DOPAMINE D3 LIGANDS (Fri, 21 Jul 2017)
>> Read More
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands (Fri, 21 Jul 2017)
>> Read More
Tropomyosin-Related Kinase Inhibitors Containing Both A 1H-Pyrazole And A Pyrimidine Moiety (Fri, 14 Jul 2017)
>> Read More
Imidazopyridazine derivatives as modulators of the GABAA receptor activity (Fri, 14 Jul 2017)
>> Read More
Salt forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-hepatonic acid (Fri, 07 Jul 2017)
>> Read More
SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS (Fri, 07 Jul 2017)
>> Read More
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors (Fri, 07 Jul 2017)
>> Read More
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors (Fri, 30 Jun 2017)
>> Read More
SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE A AND C INHIBITORS (Fri, 30 Jun 2017)
>> Read More
AMINOPYRIMIDINYL COMPOUNDS AS JAK INHIBITORS (Thu, 29 Jun 2017)
>> Read More
NOVEL FUSED PYRIDINE COMPOUNDS AS CASEIN KINASE INHIBITORS (Thu, 22 Jun 2017)
>> Read More
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands (Fri, 16 Jun 2017)
>> Read More
SUBSTITUTED PYRIDO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES (Fri, 16 Jun 2017)
>> Read More
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR (Fri, 16 Jun 2017)
>> Read More
4-(BIPHEN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZINE DERIVATIVES OF FORMULA (I) AS GABA RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF EPILEPSY AND PAIN (Fri, 16 Jun 2017)
>> Read More
SITE SPECIFIC HER2 ANTIBODY DRUG CONJUGATES (Fri, 09 Jun 2017)
>> Read More
ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION (Fri, 09 Jun 2017)
>> Read More
Site specific HER2 antibody drug conjugates (Fri, 09 Jun 2017)
>> Read More
Antibodies and antibody fragments for site-specific conjugation (Fri, 09 Jun 2017)
>> Read More
SITE SPECIFIC HER2 ANTIBODY DRUG CONJUGATES (Fri, 02 Jun 2017)
>> Read More
BENZAMIDE AND HETEROBENZAMIDE COMPOUNDS (Fri, 02 Jun 2017)
>> Read More
2-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides (Fri, 02 Jun 2017)
>> Read More
SITE SPECIFIC HER2 ANTIBODY DRUG CONJUGATES (Wed, 31 May 2017)
>> Read More
ANTIBODIES AND ANTIBODY FRAGMENTS FOR SITE-SPECIFIC CONJUGATION (Wed, 31 May 2017)
>> Read More
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES (Sat, 27 May 2017)
>> Read More
Imidazopyridazine Compounds (Fri, 26 May 2017)
>> Read More
Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole (Thu, 25 May 2017)
>> Read More
TISSUE-SPECIFIC GENOME ENGINEERING USING CRISPR-CAS9 (Fri, 19 May 2017)
>> Read More
TISSUE-SPECIFIC GENOME ENGINEERING USING CRISPR-CAS9 (Fri, 19 May 2017)
>> Read More
METHODS OF DETERMINING FEATURES OF POLYMERIC NANOPARTICLES THAT INCLUDE A THERAPEUTIC AGENT (Fri, 19 May 2017)
>> Read More
Triazine compounds as PI3 kinase and mTOR inhibitors (Fri, 05 May 2017)
>> Read More
ANTI-IL-2 ANTIBODIES AND COMPOSITIONS AND USES THEREOF (Fri, 28 Apr 2017)
>> Read More
Anti-IL-2 antibodies and compositions and uses thereof (Fri, 28 Apr 2017)
>> Read More
ANTI-IL-2 ANTIBODIES AND COMPOSITIONS AND USES THEREOF (Mon, 24 Apr 2017)
>> Read More
METHOD OF CELL CULTURE (Fri, 21 Apr 2017)
>> Read More
IMIDAZOPYRIDAZINE DERIVATIVES AS MODULATORS OF THE GABAA RECEPTOR ACTIVITY. (Thu, 20 Apr 2017)
>> Read More
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides (Wed, 12 Apr 2017)
>> Read More
Cyclopropabenzofuranyl pyridopyrazinediones (Fri, 07 Apr 2017)
>> Read More
SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO}METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE (Thu, 06 Apr 2017)
>> Read More
N-[2-(3-AMINO-2,5-DIMETHYL-1,1-DIOXIDO-5,6-DIHYDRO-2H-1,2,4-THIADIAZIN-5-YL)-1,3-THIAZOL-4-YL] AMIDES (Fri, 31 Mar 2017)
>> Read More
N-(2-(2-amino-6-substituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]OXAZIN-8a(8H)-yl)-thiazol-4-yl) amides (Fri, 31 Mar 2017)
>> Read More
N-[2-(2-amino-6,6-disubstituted-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl)-1,3-thiazol-4-yl]amides (Fri, 31 Mar 2017)
>> Read More
CELLS AND METHOD OF CELL CULTURE (Fri, 31 Mar 2017)
>> Read More
N-[2-(3-AMINO-2,5-DIMETHYL-1,1-DIOXIDO-5,6-DIHYDRO-2H-1,2,4-THIADIAZIN-5-YL)-1,3-THIAZOL-4-YL] AMIDES USEFUL AS BACE INHIBITORS (Fri, 31 Mar 2017)
>> Read More
TETRAHYDROPYRANO[3,4-D][1,3]OXAZIN DERIVATIVES AND THEIR USE AS BACE INHIBITORS (Fri, 31 Mar 2017)
>> Read More
N-[2-(2-AMINO-6,6-DISUBSTITUTED-4, 4A, 5, 6-TETRAHYDROPYRANO [3,4-D][1,3] THIAZIN-8A (8H)-YL) -1, 3-THIAZOL-4-YL] AMIDES (Fri, 31 Mar 2017)
>> Read More
N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3] thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl] amides (Fri, 31 Mar 2017)
>> Read More
NOVEL IMIDAZO [4,5-C] QUINOLINE AND IMIDAZO [4,5-C][1,5] NAPHTHYRIDINE DERIVATIVES AS LRRK2 INHIBITORS (Fri, 24 Mar 2017)
>> Read More
Novel imidazo (4,5-c) quinoline and imidazo (4,5-c)(1,5) naphthyridine derivatives as LRRK2 inhibitors (Fri, 24 Mar 2017)
>> Read More
HUMANIZED ANTIBODIES (Fri, 17 Mar 2017)
>> Read More
TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF (Fri, 17 Mar 2017)
>> Read More
Crystalline form of 6-[(4R)-4-methyl-1,2-dioxido-1,2,6-thiadiazinan-2-yl]iosoquinoline-1-carbonitrile (Fri, 17 Mar 2017)
>> Read More
Pyrazolopyridines and pyrazolopyrimidines (Fri, 17 Mar 2017)
>> Read More
Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors (Fri, 17 Mar 2017)
>> Read More
Methyl-and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof (Fri, 17 Mar 2017)
>> Read More
Heteroaromatic compounds and their use as dopamine D1 ligands (Fri, 03 Mar 2017)
>> Read More
BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS (Fri, 03 Mar 2017)
>> Read More
BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AS IRAK4 MODULATORS (Fri, 03 Mar 2017)
>> Read More
Aminopyrimidinyl compounds as JAK inhibitors (Fri, 03 Mar 2017)
>> Read More
Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole (Fri, 03 Mar 2017)
>> Read More
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators (Fri, 03 Mar 2017)
>> Read More
Cycloalkyl-Linked Diheterocycle Derivatives (Fri, 24 Feb 2017)
>> Read More
TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF (Fri, 24 Feb 2017)
>> Read More
Tissue factor pathway inhibitor antibodies and uses thereof (Fri, 24 Feb 2017)
>> Read More
Crystalline form of 6-[(4r)-4-methyl-1,2-dioxido-1,2,6-thiadiazinan-2-yl]isoquinoline-1-carbonitrile (Thu, 23 Feb 2017)
>> Read More
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8h)-yl-1,3-thiazol-4-yl amides (Thu, 23 Feb 2017)
>> Read More
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of asgpr (Thu, 23 Feb 2017)
>> Read More
TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES (Mon, 20 Feb 2017)
>> Read More
Heterocyclic compounds and their use as dopamine D1 ligands (Fri, 17 Feb 2017)
>> Read More
BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS (Fri, 17 Feb 2017)
>> Read More
3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE (Fri, 17 Feb 2017)
>> Read More
3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE (Fri, 17 Feb 2017)
>> Read More
BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS (Fri, 17 Feb 2017)
>> Read More
Bicyclic-fused heteroaryl or aryl compounds (Fri, 17 Feb 2017)
>> Read More
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof (Thu, 16 Feb 2017)
>> Read More
Heteroaromatic compounds and their use as dopamine D1 ligands (Fri, 10 Feb 2017)
>> Read More
Heteroaromatic compounds and their use as dopamine D1 ligands (Fri, 10 Feb 2017)
>> Read More
CRYSTALLINE FORM OF LORLATINIB FREE BASE (Fri, 10 Feb 2017)
>> Read More
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,1-TRIFLUORO-4-HYDROXYBUTAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS (Fri, 10 Feb 2017)
>> Read More
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors (Fri, 10 Feb 2017)
>> Read More
Crystalline form of lorlatinib free base (Fri, 10 Feb 2017)
>> Read More
1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors (Fri, 03 Feb 2017)
>> Read More
Stability-modulating linkers for use with antibody drug conjugates (Fri, 03 Feb 2017)
>> Read More
Imidazopyridazine compounds (Fri, 03 Feb 2017)
>> Read More
1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,1-TRIFLUORO-4-HYDROXYBUTAN-2-YL CARBAMATE DERIVATIVES (Wed, 01 Feb 2017)
>> Read More
CRYSTALLINE FORM OF LORLATINIB FREE BASE (Wed, 01 Feb 2017)
>> Read More
IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF (Fri, 27 Jan 2017)
>> Read More
ANTIBODIES TO COAGULATION FACTOR XIA AND USES THEREOF (Fri, 27 Jan 2017)
>> Read More
IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF (Fri, 27 Jan 2017)
>> Read More
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof (Fri, 27 Jan 2017)
>> Read More
DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS FOR USE IN THE TREATMENT OF METABOLIC AND RELATED DISORDERS (Thu, 26 Jan 2017)
>> Read More
IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF (Sun, 22 Jan 2017)
>> Read More
ANTI-NOTCH3 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES (Fri, 20 Jan 2017)
>> Read More
Spliceostatin analogs and methods for their preparation (Fri, 20 Jan 2017)
>> Read More
Pyrimidine derivatives (Fri, 20 Jan 2017)
>> Read More
PYRIMIDINE DERIVATIVES (Fri, 20 Jan 2017)
>> Read More
PROCEDURES FOR THE EXTRACTION AND ISOLATION OF BACTERIAL CAPSULAR POLYSACCHARIDES FOR USE AS VACCINES OR LINKED TO PROTEINS AS CONJUGATES VACCINES (Thu, 19 Jan 2017)
>> Read More
PYRIMIDINE DERIVATIVES (Mon, 16 Jan 2017)
>> Read More
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides (Fri, 13 Jan 2017)
>> Read More
IMMUNOGENIC GLYCOPROTEIN CONJUGATES (Fri, 13 Jan 2017)
>> Read More
SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH (Fri, 06 Jan 2017)
>> Read More
3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors (Fri, 06 Jan 2017)
>> Read More
SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS (Fri, 30 Dec 2016)
>> Read More
NOVEL PYRIDINE PYRAZINONES AS BET-FAMILY BROMODOMAIN INHIBITORS (Fri, 23 Dec 2016)
>> Read More
TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS (Fri, 23 Dec 2016)
>> Read More
NOVEL PYRIDO[2,3-B]PYRAZINONES AS BET-FAMILY BROMODOMAIN INHIBITORS (Fri, 23 Dec 2016)
>> Read More
TRICYCLIC COMPOUNDS AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS (Fri, 23 Dec 2016)
>> Read More
NOVEL PYRIDINE PYRAZINONES AS BRD4 INHIBITORS (Mon, 19 Dec 2016)
>> Read More
GLUCAGON RECEPTOR MODULATORS (Fri, 16 Dec 2016)
>> Read More
Bispecific heterodimeric diabodies and uses thereof (Fri, 16 Dec 2016)
>> Read More
Pyrazolopyridines and pyrazolopyrimidines (Wed, 14 Dec 2016)
>> Read More
NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME (Fri, 09 Dec 2016)
>> Read More
NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME (Fri, 09 Dec 2016)
>> Read More
<i>Neisseria meningitidis </i>composition and methods thereof (Fri, 02 Dec 2016)
>> Read More
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors (Fri, 02 Dec 2016)
>> Read More
Bicyclic-fused heteroaryl or aryl compounds (Fri, 02 Dec 2016)
>> Read More
Pyrazolopyridines and pyrazolopyrimidines (Fri, 02 Dec 2016)
>> Read More
Drug loaded polymeric nanoparticles and methods of making and using same (Fri, 25 Nov 2016)
>> Read More
Substituted dihydroisoquinolinone compounds (Fri, 25 Nov 2016)
>> Read More
Process for annealing amorphous atorvastatin (Fri, 18 Nov 2016)
>> Read More
COMBINATIONS COMPRISING A PYRROLIDINE-2,5-DIONE IDO1 INHIBITOR AND AN ANTI-BODY (Fri, 18 Nov 2016)
>> Read More
COMBINATIONS COMPRISING A PYRROLIDINE-2,5-DIONE IDO1 INHIBITOR AND AN ANTI-BODY (Fri, 18 Nov 2016)
>> Read More
POLYMORPH FORMS OF PYRROLIDINE-2,5-DIONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE AS IDO1 INHIBITORS (Fri, 18 Nov 2016)
>> Read More
Carbonitrile derivatives as selective androgen receptor modulators (Fri, 18 Nov 2016)
>> Read More
POLYMORPH FORMS OF PYRROLIDINE-2,5-DIONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF (Tue, 15 Nov 2016)
>> Read More
COMBINATION THERAPIES COMPRISING A PYRROLIDINE-2,5-DIONE IDO1 INHIBITOR AND AN ANTI-PD1/ANTI-PD-L1 ANTIBODY (Tue, 15 Nov 2016)
>> Read More
COMBINATION THERAPIES COMPRISING A PYRROLIDINE-2,5-DIONE IDO1 INHIBITOR (Tue, 15 Nov 2016)
>> Read More
2-thiopyrimidinones (Fri, 11 Nov 2016)
>> Read More
2-THIOPYRIMIDINONES (Fri, 11 Nov 2016)
>> Read More
PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL, PYRROLO[2,3-B]PYRIDINYL ACRYLAMIDES AND EPOXIDES THEREOF (Fri, 11 Nov 2016)
>> Read More
GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF (Fri, 11 Nov 2016)
>> Read More
Anti-PTK7 antibody-drug conjugates (Fri, 11 Nov 2016)
>> Read More
2-thiopyrimidinones (Fri, 11 Nov 2016)
>> Read More
PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL, PYRROLO[2,3-B]PYRIDINYL ACRYLAMIDES AND EPOXIDES THEREOF (Fri, 11 Nov 2016)
>> Read More
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR (Fri, 11 Nov 2016)
>> Read More
Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction (Fri, 11 Nov 2016)
>> Read More
Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof (Fri, 11 Nov 2016)
>> Read More
Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders (Thu, 10 Nov 2016)
>> Read More
2-THIOPYRIMIDINONES (Sun, 06 Nov 2016)
>> Read More
GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF (Sat, 05 Nov 2016)
>> Read More
ANTI-ESTROGENIC COMPOUNDS (Fri, 04 Nov 2016)
>> Read More
ANTI-ESTROGENIC COMPOUNDS (Fri, 28 Oct 2016)
>> Read More
CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA MALEATE (Fri, 28 Oct 2016)
>> Read More
ANTI-ESTROGENIC COMPOUNDS (Fri, 28 Oct 2016)
>> Read More
CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA MALEATE (Fri, 28 Oct 2016)
>> Read More
Cycloalkyl-linked diheterocycle derivatives (Fri, 28 Oct 2016)
>> Read More
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides (Thu, 27 Oct 2016)
>> Read More
NOVEL 3,4-DISUBSTITUTED-1H-PYRROLO[2,3-B]PYRIDINES AND 4,5-DISUBSTITUTED-7H-PYRROLO[2,3-C]PYRIDAZINES AS LRRK2 INHIBITORS (Thu, 27 Oct 2016)
>> Read More
CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA MALEATE (Tue, 25 Oct 2016)
>> Read More
Diacylglycerol acyltransferase 2 inhibitors (Fri, 21 Oct 2016)
>> Read More
2-thiopyrimidinones (Fri, 21 Oct 2016)
>> Read More
Heteroaromatic compounds and their use as dopamine D1 ligands (Fri, 21 Oct 2016)
>> Read More
Crystalline form of 6-((4R)-4-methyl-1,2-dioxido-1,2,6-thiadiazinan-2-yl)isoquinoline-1-carbonitrile (Fri, 21 Oct 2016)
>> Read More
Bicyclic-fused heteroaryl or aryl compounds and their use as IRAK4 inhibitors (Fri, 14 Oct 2016)
>> Read More
PYRROLO[2,3-D]PYRIMIDINYL, PYRROLO[2,3-B]PYRAZINYL AND PYRROLO[2,3-D]PYRIDINYL ACRYLAMIDES (Thu, 13 Oct 2016)
>> Read More
2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides (Fri, 07 Oct 2016)
>> Read More
BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE (Fri, 30 Sep 2016)
>> Read More
Bifunctional cytotoxic agents containing the CTI pharmacophore (Fri, 30 Sep 2016)
>> Read More
Neisseria meningitidis compositions and methods thereof (Fri, 30 Sep 2016)
>> Read More
Heteroaromatic compounds and their use as dopamine D1 ligands (Fri, 30 Sep 2016)
>> Read More
BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE (Fri, 23 Sep 2016)
>> Read More
HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF (Fri, 23 Sep 2016)
>> Read More
3-indol substituted derivatives, pharmaceutical compositions and methods for use (Fri, 23 Sep 2016)
>> Read More
NOVEL 3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE (Fri, 23 Sep 2016)
>> Read More
Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use (Fri, 23 Sep 2016)
>> Read More
NOVEL 3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE (Fri, 23 Sep 2016)
>> Read More
Chromene and 1,1 a,2,7b-tetrahydrocyclopropa[c]chromene pyridopyrazinediones as gamma-secretase modulators (Fri, 23 Sep 2016)
>> Read More
BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE (Wed, 21 Sep 2016)
>> Read More
Intermediates and methods for synthesizing calicheamicin derivatives (Fri, 02 Sep 2016)
>> Read More
SUBSTITUTED NUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS (Fri, 02 Sep 2016)
>> Read More
Diacylglycerol acyltransferase 2 inhibitors for use in the treatment of metabolic and related disorders (Fri, 02 Sep 2016)
>> Read More
Substituted nucleoside derivatives useful as anticancer agents (Fri, 02 Sep 2016)
>> Read More
SUBSTITUTED NUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS (Fri, 26 Aug 2016)
>> Read More
SUBSTITUTED NUCLEOSIDE DERIVATIVES AS PRMT5 INHIBITORS (Thu, 25 Aug 2016)
>> Read More
ANTAGONISTS OF PROSTAGLANDIN EP3 RECEPTOR (Thu, 18 Aug 2016)
>> Read More
Process for the preparation of voriconazole and analogues thereof (Fri, 12 Aug 2016)
>> Read More
NOVEL CYCLOPROPABENZOFURANYL PYRIDOPYRAZINEDIONES (Fri, 12 Aug 2016)
>> Read More
USE OF ACETYL-COA CARBOXYLASE INHIBITORS FOR TREATING ACNE VULGARIS (Fri, 05 Aug 2016)
>> Read More
Combination Therapy for Tuberculosis (Fri, 05 Aug 2016)
>> Read More
N-Acylpyrrolidine Ether Tropomyosin-Related Kinase Inhibitors (Fri, 05 Aug 2016)
>> Read More
Novel Cyclopropabenzofuranyl Pyridopyrazinediones (Fri, 05 Aug 2016)
>> Read More
SULFONAMIDE-SUBSITUTED INDOLE MODULATORS OF RORC2 AND METHODS OF USE THEREOF (Fri, 05 Aug 2016)
>> Read More
METHOXY-SUBSTITUTED PYRROLOPYRIDINE MODULATORS OF RORC2 AND METHODS OF USE THEREOF (Fri, 05 Aug 2016)
>> Read More
METHOXY-SUBSTITUTED PYRROLOPYRIDINE MODULATORS OF RORC2 AND METHODS OF USE THEREOF (Fri, 05 Aug 2016)
>> Read More
NOVEL CYCLOPROPABENZOFURANYL PYRIDOPYRAZINEDIONES (Thu, 04 Aug 2016)
>> Read More
KAT II INHIBITORS (Mon, 01 Aug 2016)
>> Read More
Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR (Fri, 22 Jul 2016)
>> Read More
Therapeutic Antibody (Fri, 22 Jul 2016)
>> Read More
CRIZOTINIB FOR USE IN THE TREATMENT OF CANCER (Fri, 22 Jul 2016)
>> Read More
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES (Fri, 22 Jul 2016)
>> Read More
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof (Fri, 22 Jul 2016)
>> Read More
Immunogenic compositions for use in pneumococcal vaccines (Fri, 22 Jul 2016)
>> Read More
Bifunctional cytotoxic agents (Fri, 22 Jul 2016)
>> Read More
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES (Sat, 16 Jul 2016)
>> Read More
Heteroaromatic compounds and their use as dopamine D1 ligands (Fri, 15 Jul 2016)
>> Read More
DOSAGE REGIMEN FOR MADCAM ANTAGONISTS (Fri, 15 Jul 2016)
>> Read More
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof (Fri, 15 Jul 2016)
>> Read More
Dosage regimen for MAdCAM antagonists (Fri, 15 Jul 2016)
>> Read More
Site Search
